Published through 2026-11-02 17:05 UTC · Automated cloud publishing.
Bronwyn Brophy O’Connor Named Carl Zeiss Meditec CEO Effective December 2026
Understand the event
Carl Zeiss Meditec AG has officially announced that Bronwyn Brophy O’Connor will assume the position of Chief Executive Officer effective December 1, 2026. This leadership transition marks a significant change for the medical technology company, as O’Connor succeeds Andreas Pecher, who has held the top executive role prior to this announcement. Currently serving as the CEO of Vitrolife Group in Sweden, O’Connor brings experience from another prominent entity within the life sciences and diagnostic sectors. The report by Vision Monday confirms the specific start date for her tenure, establishing a clear timeline for the handover of responsibilities. As of the latest reporting on October 27, 2026, no further details regarding the strategic implications of this appointment or additional changes within the executive board have been disclosed. The focus remains on the confirmed succession plan, with O’Connor’s current role at Vitrolife Group noted as her immediate predecessor position before joining Carl Zeiss Meditec.
AI-generated from reporting · updated 6 days ago
Reporting timeline
Follow the reporting for different perspectives.
- Vision Monday — BusinessBronwyn Brophy O’Connor to Become Carl Zeiss Meditec CEO on December 1, 2026
Carl Zeiss Meditec AG announced that Bronwyn Brophy O’Connor will assume the role of CEO effective December 1, 2026. Currently serving as CEO of Vitrolife Group in Sweden, O’Connor succeeds Andreas Pecher, who has held the interim position since January 1, 2026. The appointment, initially revealed in May 2026, also places her on the executive board of Carl Zeiss AG with responsibility for the medical technology segment. As of the start date, the management board of Carl Zeiss Meditec AG will consist of O’Connor and Chief Financial Officer Justus Wehmer. Supervisory board chairman Peter Kameritsch highlighted her international medtech experience and customer-focused approach.
Event coverage trend
Current coverage 3·Comparable peak 10（10-27 13:00）·Comparable change over 24 hours -51%
Trends compare continuously observed participants only; coverage may be narrower than the current total. Point, click or use arrow keys to inspect hourly values.